Medical Device News Magazine

BDC Laboratories Introduces Software to Simplify Complex GOA Determination for Prosthetic Heart Valves

Statys® GOA makes it possible to perform quantitative GOA analysis

About Medical Device News Magazine

About Medical Device News Magazine. We are a digital publication founded in 2008 located in the United States.

Advertise with Medical Device News Magazine! Join Our #1 Family of Advertisers!

We pride ourselves on being the best-kept secret when it comes to distributing your news! Our unique digital approach enables us to circulate your...

Statys® GOA software

Biomedical Device Consultants and Laboratories (BDC Laboratories) introduced its Statys® GOA software today at MD&M West. This equipment-agnostic program simplifies and automates geometric orifice area (GOA) analysis in prosthetic heart valves.

GOA analysis is a multi-dimensional imaging challenge because heart valve substitutes have complex geometries and perform nuanced movements. Statys® GOA is the first purpose-built software for quantitative comparison of heart valve leaflet opening area between hydrodynamic testing and accelerated wear testing. It’s designed to help engineering teams better comply with ISO 5840.

Learn more about the software here: https://www.bdclabs.com/testing-equipment/statys-goa-software/

Analyzes Videos and Still Images

Statys® GOA automatically analyzes video and still images, overlays boundaries, and determines the GOA for each frame, making analysis efficient, accurate, and simple. Image contrast is crucial in GOA analysis because, without clear differentiation between the leaflet edges and the background, it’s challenging to achieve accurate measurements using edge detection. With multiple algorithms for tailoring analysis and correcting image quality, it’s easy to fix less-than-ideal lighting conditions that traditionally confound these measurements.

With an intuitive interface and automated report generation, it’s easy for anyone on the team to keep track of test results and avoid knowledge transfer gaps.

A Proven Path to GOA Analysis

“This software takes an esoteric, complex measurement and simplifies it,” said Craig Weinberg, PhD, Chief Technology Officer, BDC Laboratories. “It’s a very purpose-developed software. Statys® GOA does one thing really well—and that’s quantifying the opening area of a valve throughout the cardiac cycle.”

Today, some engineering teams create their own GOA analysis algorithms in general-purpose software platforms. With Statys® GOA, BDC Laboratories is leveraging decades of experience to ensure efficient and insightful GOA analysis, even for teams with limited resources.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Other News

Shoulder Innovations Further Strengthens IP Portfolio in Key Areas with Recent Patent Grants

"These recent grants further strengthen key patent families that are foundational to our technology, and we are pleased the USPTO continues to recognize our meaningful innovation in the shoulder arthroplasty segment," said Rob Ball, CEO of Shoulder Innovations. "This noteworthy expansion of our IP position represents the culmination of over 10 years of research and development, and we are proud of our team for their continued dedication to creating practical solutions for shoulder surgeons and advancing patient outcomes."

Radical Catheter Technologies Presents Analysis of Disruptive, Recently FDA-Cleared Endovascular Technology at the Society of NeuroInterventional Surgery 21st Annual Meeting

This new catheter, the first product commercialized from this novel technology platform, is designed to enable access to the blood vessels in the brain for both femoral and radial access. A multi-center analysis of this disruptive technology is being presented today at Society of NeuroInterventional Surgery 21st annual meeting. In addition, the Company confirmed the closing of a $20 million financing round led by NeuroTechnology Investors, which will be used to scale the company and expand the Radical platform notes Radical Catheter Technologies.

Rapid Medical™ Completes Initial Neurovascular Cases in the USA Following FDA Clearance of Its Active Access Solution

“With DRIVEWIRE, our design goal was to bring new levels of access and control to the interventional suite while improving best-in-class guidewires,” comments Giora Kornblau, Chief Technology Officer at Rapid Medical. “When physicians are looking for technologies that increase the clinical possibilities and safety for the patient, we want Rapid to be the first place they look.”